E-LIB Suche - Ergebnisse für: Pointet, Anne-Laure

1

Three fluoropyrimidine-based regimens in routine clinical p..:

Pointet, Anne-Laure ; Tougeron, David ; Pernot, Simon...
Clinics and Research in Hepatology and Gastroenterology. 44 (2020) 3 - p. 295-301 , 2020

Link: https://doi.org/10.1016/..

2

Gemcitabine plus nab-paclitaxel until progression or altern..:

Rinaldi, Yves ; Pointet, Anne-Laure ; Khemissa Akouz, Faiza...
European Journal of Cancer. 136 (2020) - p. 25-34 , 2020

Link: https://doi.org/10.1016/..

3

Folfirinox versus gemcitabine/nab-paclitaxel as first-line ..:

Williet, Nicolas ; Saint, Angélique ; Pointet, Anne-Laure...
Therapeutic Advances in Gastroenterology. 12 (2019) - p. 175628481987866 , 2019

Link: https://doi.org/10.1177/..

4

Prediction of survival with second-line therapy in biliary ..:

Neuzillet, Cindy ; Casadei Gardini, Andrea ; Brieau, Bertrand...
European Journal of Cancer. 111 (2019) - p. 94-106 , 2019

Link: https://doi.org/10.1016/..

5

Prognostic value of health-related quality of life in patie..:

Diouf, Momar ; Filleron, Thomas ; Pointet, Anne-Laure...
Quality of Life Research. 25 (2016) 7 - p. 1713-1723 , 2016

Link: https://www.jstor.org/st..

6

Additive value of pre-operative and one-month post-operativ..:

d'Engremont, Christelle ; Vernerey, Dewi ; Pointet, Anne-Laure...
BMC Cancer. 16 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

7

Prognostic value of health-related quality of life in patie..:

Diouf, Momar ; Filleron, Thomas ; Pointet, Anne-Laure...
Quality of Life Research. 25 (2015) 7 - p. 1713-1723 , 2015

Link: https://doi.org/10.1007/..

8

5-FU or mitomycin C hepatic arterial infusion after failure..:

Pernot, Simon ; Velut, Guillaume ; Kourie, Rapahel Hampig...
Clinics and Research in Hepatology and Gastroenterology. 42 (2018) 3 - p. 255-260 , 2018

Link: https://doi.org/10.1016/..

9

Three fluoropyrimidine-based regimens in routine clinical p..:

Pointet, Anne-Laure ; Tougeron, David ; Pernot, Simon...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.clinre.2019.08.009. , 2020

Link: https://hal.science/hal-..

10

Three fluoropyrimidine-based regimens in routine clinical p..:

Pointet, Anne-Laure ; Tougeron, David ; Pernot, Simon...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.clinre.2019.08.009. , 2020

Link: https://hal.science/hal-..

11

Three fluoropyrimidine-based regimens in routine clinical p..:

Pointet, Anne-Laure ; Tougeron, David ; Pernot, Simon...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.clinre.2019.08.009. , 2020

Link: https://hal.science/hal-..

12

Folfirinox versus gemcitabine/nab-paclitaxel as first-line ..:

Williet, Nicolas ; Saint, Angélique ; Pointet, Anne-Laure...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764033/. , 2019

Link: http://www.ncbi.nlm.nih...

13

Folfirinox versus gemcitabine/nab-paclitaxel as first-line ..:

Williet, Nicolas ; Saint, Angélique ; Pointet, Anne-Laure...
info:eu-repo/semantics/altIdentifier/doi/10.1177/1756284819878660. , 2019

Link: https://hal.science/hal-..

14

Folfirinox versus gemcitabine/nab-paclitaxel as first-line ..:

Williet, Nicolas ; Saint, Angélique ; Pointet, Anne-Laure...
info:eu-repo/semantics/altIdentifier/doi/10.1177/1756284819878660. , 2019

Link: https://hal.science/hal-..

15

Folfirinox versus gemcitabine/nab-paclitaxel as first-line ..:

Williet, Nicolas ; Saint, Angélique ; Pointet, Anne-Laure...
info:eu-repo/semantics/altIdentifier/doi/10.1177/1756284819878660. , 2019

Link: https://hal.science/hal-..